Study Reveals Cannabis Use Doubles Heart Disease Mortality Risk

A recent study published in the journal Heart reveals that individuals who use cannabis or synthetic cannabinoids face a doubled risk of dying from heart-related issues compared to non-users. This alarming finding comes amidst increasing recreational use of cannabis across Europe, where it remains the most popular drug despite its illegal status in many countries. The study highlights the evolving potency and diversity of cannabis products, raising concerns about their health implications

The research, conducted by a French team, analyzed data from 24 studies between 2016 and 2023, involving participants aged 19 to 59. The results indicated not only a doubled mortality risk but also a 20% increased likelihood of stroke and a 29% heightened risk of heart attacks or acute coronary syndrome among cannabis users. Although most studies were observational and could not definitively establish causation, the comprehensive nature of this analysis underscores the potential cardiovascular risks associated with cannabis consumption

Experts Stanton Glantz and Dr. Lynn Silver from the University of California at San Francisco, who were not part of the study, emphasize the need for health warnings on cannabis products and measures to limit exposure to secondhand smoke. As cannabis laws become more lenient globally, they advocate for incorporating cannabis into cardiovascular disease prevention frameworks. The study's findings challenge the perception of cannabis as a low-risk substance, prompting calls for further research to understand the nuances of its impact on heart health